Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I/II Pilot Clinical Trial to Evaluate the Efficacy and Safety of Ebola Virus Disease (EVD) Convalescent Plasma (ECP) for Treatment of EVD

NCT02333578 is registered in ClinicalTrials.gov with Clinical Research Management, Inc. as lead sponsor.

NCT NCT02333578
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02333578 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I/II Pilot Clinical Trial to Evaluate the Efficacy and Safety of Ebola Virus Disease (EVD) Convalescent Plasma (ECP) for Treatment of EVD
Lead sponsor
Clinical Research Management, Inc.
Phase
Not applicable
Overall status
Unknown status
Start date
November 30, 2014
Completion date
June 30, 2015
Enrollment
70 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ebola virus disease